215 related articles for article (PubMed ID: 14962202)
1. Central venous access devices in haemophilia.
Valentino LA; Ewenstein B; Navickis RJ; Wilkes MM
Haemophilia; 2004 Mar; 10(2):134-46. PubMed ID: 14962202
[TBL] [Abstract][Full Text] [Related]
2. Central venous access device-related infections in patients with haemophilia.
Yeoh ZH; Furmedge J; Ekert J; Crameri J; Curtis N; Barnes C
J Paediatr Child Health; 2013 Mar; 49(3):242-5. PubMed ID: 23438133
[TBL] [Abstract][Full Text] [Related]
3. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).
Langley AR; Stain AM; Chan A; McLimont M; Chait S; Wu J; Poon MC; Card R; Israels SJ; Laferriere N; Klaassen RJ; Rivard GE; Cloutier S; Hawes S; Feldman B; Blanchette V
Haemophilia; 2015 Jul; 21(4):469-76. PubMed ID: 26104147
[TBL] [Abstract][Full Text] [Related]
4. Monthly recombinant tissue plasminogen activator administration to implantable central venous access devices decreases infections in children with haemophilia.
Jeng MR; O'Brien M; Wong W; Zoland J; Lea J; Tang N; Glader B
Haemophilia; 2009 Nov; 15(6):1272-80. PubMed ID: 19601989
[TBL] [Abstract][Full Text] [Related]
5. Complications of central venous access devices in paediatric haemophilia patients.
Domm JA; Hudson MG; Janco RL
Haemophilia; 2003 Jan; 9(1):50-6. PubMed ID: 12558778
[TBL] [Abstract][Full Text] [Related]
6. Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study.
Rodriguez V; Mancuso ME; Warad D; Hay CR; DiMichele DM; Valentino L; Kenet G; Kulkarni R
Haemophilia; 2015 Sep; 21(5):e369-74. PubMed ID: 26178581
[TBL] [Abstract][Full Text] [Related]
7. Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders.
Komvilaisak P; Connolly B; Naqvi A; Blanchette V
Haemophilia; 2006 Dec; 12 Suppl 6():87-93. PubMed ID: 17123400
[TBL] [Abstract][Full Text] [Related]
8. MRI after removal of central venous access device reveals a high number of asymptomatic thromboses in children with haemophilia.
Ranta S; Kalajoki-Helmiö T; Pouttu J; Mäkipernaa A
Haemophilia; 2012 Jul; 18(4):521-6. PubMed ID: 22176603
[TBL] [Abstract][Full Text] [Related]
9. Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator.
McCarthy CE; O'Brien M; Andrews J; Zoland JM; Macasiray E; Wong W; Lo C; Glader B; Tamaresis J; Jeng M
Haemophilia; 2016 Jan; 22(1):81-6. PubMed ID: 26248602
[TBL] [Abstract][Full Text] [Related]
10. Central venous access devices for paediatric patients with haemophilia: a single-institution experience.
Titapiwatanakun R; Moir C; Pruthi RK; Stavlo PL; Schmidt KA; Rodriguez V
Haemophilia; 2009 Jan; 15(1):168-74. PubMed ID: 19149849
[TBL] [Abstract][Full Text] [Related]
11. The use of central venous catheters in haemophilia patients.
Izzi G; Franchini M; Bonetti L; Tagliaferri A
Haemophilia; 2010 Jan; 16 Suppl 1():29-31. PubMed ID: 20059567
[TBL] [Abstract][Full Text] [Related]
12. Burden of illness and costs among paediatric haemophilia patients with and without central venous access devices treated in US hospitals.
Buckley B; Dreyfus J; Prasad M; Gayle J; Kendter J; Hall E
Haemophilia; 2018 May; 24(3):e93-e102. PubMed ID: 29577531
[TBL] [Abstract][Full Text] [Related]
13. Consensus recommendations for use of central venous access devices in haemophilia.
Ewenstein BM; Valentino LA; Journeycake JM; Tarantino MD; Shapiro AD; Blanchette VS; Hoots WK; Buchanan GR; Manco-Johnson MJ; Rivard GE; Miller KL; Geraghty S; Maahs JA; Stuart R; Dunham T; Navickis RJ
Haemophilia; 2004 Sep; 10(5):629-48. PubMed ID: 15357790
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of central venous access devices in children with haemophilia.
Upadhyaya M; Richards M; Buckham S; Squire BR
Pediatr Surg Int; 2009 Jun; 25(6):503-6. PubMed ID: 19455342
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of infectious complications associated with central venous access devices in children with haemophilia.
Tarantino MD; Lail A; Donfield SM; Lynn H; Peddle L; Hunsberger S; Shapiro AD
Haemophilia; 2003 Sep; 9(5):588-92. PubMed ID: 14511299
[TBL] [Abstract][Full Text] [Related]
16. Central venous access devices in children with congenital coagulation disorders: complications and long-term outcome.
McMahon C; Smith J; Khair K; Liesner R; Hann IM; Smith OP
Br J Haematol; 2000 Aug; 110(2):461-8. PubMed ID: 10971409
[TBL] [Abstract][Full Text] [Related]
17. Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland.
Vepsäläinen K; Lassila R; Arola M; Lähteenmäki P; Möttönen M; Mäkipernaa A; Riikonen P
Haemophilia; 2015 Nov; 21(6):747-53. PubMed ID: 25832453
[TBL] [Abstract][Full Text] [Related]
18. Central venous access device infections in children with hemophilia: a comparison of prophylaxis and episodic therapy.
Hacker MR; Page JH; Shapiro AD; Rich-Edwards JW; Manco-Johnson MJ
J Pediatr Hematol Oncol; 2007 Jul; 29(7):458-64. PubMed ID: 17609623
[TBL] [Abstract][Full Text] [Related]
19. Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review.
Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
Int J Nurs Stud; 2016 Jul; 59():177-96. PubMed ID: 27222463
[TBL] [Abstract][Full Text] [Related]
20. Venous access in haemophilic children: choice and management.
Santagostino E; Mancuso ME
Haemophilia; 2010 Jan; 16 Suppl 1():20-4. PubMed ID: 20059565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
